Cushman & Wakefield reprices $840 million term loan at lower rate

Published 02/10/2025, 21:38
Cushman & Wakefield reprices $840 million term loan at lower rate

NEW YORK - Commercial real estate services firm Cushman & Wakefield (NYSE:CWK) has completed a repricing of approximately $840 million of its Term Loan, reducing the applicable interest rate by 25 basis points from Term SOFR plus 2.75% to Term SOFR plus 2.50%, the company announced Thursday.

The Term Loan, which was issued in January 2025, maintains its original maturity date of January 2030 with all other terms remaining substantially unchanged, according to the company statement.

This repricing follows the company’s August 5 prepayment of $150 million on the same Term Loan. With this prepayment, Cushman & Wakefield has repaid $200 million in debt year-to-date and $400 million since the beginning of 2024.

"We’re incredibly pleased to have completed another successful repricing of our term loan debt, achieving the lowest margin on our term loans since going public in 2018," said Neil Johnston, Chief Financial Officer of Cushman & Wakefield, in the press release.

Cushman & Wakefield is a global commercial real estate services firm with approximately 52,000 employees across nearly 400 offices in 60 countries. The company reported revenue of $9.4 billion in 2024 across its core service lines of Services, Leasing, Capital markets and Valuation and other.

The information in this article is based on a company press release.

In other recent news, Cushman & Wakefield reported strong financial results for the second quarter of 2025, surpassing Wall Street expectations. The company’s earnings per share reached $0.30, significantly beating the forecasted $0.22, while revenue hit $2.48 billion, exceeding the expected $2.38 billion. Following these results, Goldman Sachs upgraded Cushman & Wakefield from Sell to Buy, setting a price target of $17.50, citing improved performance in several key areas. Additionally, Citizens JMP raised its price target to $16.00, maintaining a Market Outperform rating, as the company demonstrated 7% organic revenue growth and increased its full-year outlook. Raymond James also raised its price target to $17.00, highlighting improvements in free cash flow generation and reduced leverage. In another development, Cushman & Wakefield received support from Institutional Shareholder Services for its proposed redomiciliation to Bermuda, which the company believes offers economic savings and tax neutrality. These recent developments reflect a period of positive momentum for Cushman & Wakefield.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.